130 related articles for article (PubMed ID: 2128545)
1. T cell-dependent immunodepression in vivo in Schistosoma mansoni infected patients.
Muniz-Junqueira MI; Tosta CE; Prata A
Rev Soc Bras Med Trop; 1990; 23(1):27-31. PubMed ID: 2128545
[TBL] [Abstract][Full Text] [Related]
2. Specific treatment of hepatosplenic schistosomiasis can increase T-lymphocyte reactivity.
Muniz-Junqueira MI; Tavares-Neto J; Ataide M; Prata A; Tosta CE
Rev Soc Bras Med Trop; 1991; 24(2):97-9. PubMed ID: 1841433
[TBL] [Abstract][Full Text] [Related]
3. Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease.
Colley DG; Garcia AA; Lambertucci JR; Parra JC; Katz N; Rocha RS; Gazzinelli G
Am J Trop Med Hyg; 1986 Jul; 35(4):793-802. PubMed ID: 3089040
[TBL] [Abstract][Full Text] [Related]
4. Immunology of hepatosplenic schistosomiasis mansoni: a human perspective.
Dunne DW; Pearce EJ
Microbes Infect; 1999 Jun; 1(7):553-60. PubMed ID: 10603572
[No Abstract] [Full Text] [Related]
5. Antibody response to Salmonella typhi in human schistosomiasis mansoni.
Muniz-Junqueira MI; Tavares-Neto J; Prata A; Tosta CE
Rev Soc Bras Med Trop; 1996; 29(5):441-5. PubMed ID: 8885672
[TBL] [Abstract][Full Text] [Related]
6. Immune profiles in hepatosplenic schistosomiasis mansoni after surgical treatments.
Petroianu A; Antunes LJ
J Int Med Res; 1998; 26(1):43-9. PubMed ID: 9513076
[TBL] [Abstract][Full Text] [Related]
7. Detection of immune complexes in ascitic fluid of hepatosplenic schistosomiasis.
Khalil HM; Makled MK; el Sebai MM; el Naggar MK
J Egypt Soc Parasitol; 1987 Dec; 17(2):699-705. PubMed ID: 3121767
[No Abstract] [Full Text] [Related]
8. Suppression splenic T lymphocytes in human hepatosplenic Schistosomiasis mansoni.
Ellner JJ; Olds GR; Kamel R; Osman GS; el-Kholy A; Mahmoud AA
J Immunol; 1980 Jul; 125(1):308-12. PubMed ID: 6966656
[TBL] [Abstract][Full Text] [Related]
9. Humoral immune responses in human hepatosplenic schistosomiasis mansoni.
Goodgame RW; Colley DG; Draper CC; Lewis FA; McLaren ML; Pelley RP
Am J Trop Med Hyg; 1978 Nov; 27(6):1174-80. PubMed ID: 727322
[TBL] [Abstract][Full Text] [Related]
10. Immune responses during human schistosomiasis mansoni. IX. T-lymphocyte subset analysis by monoclonal antibodies in hepatosplenic disease.
Colley DG; Katz N; Rocha RS; Abrantes W; da Silva AL; Gazzinelli G
Scand J Immunol; 1983 Apr; 17(4):297-302. PubMed ID: 6601292
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide monocyte production levels in patients with the hepatosplenic form of schistosomiasis mansoni who underwent splenectomy, ligature of the left gastric vein and auto implantation of spleen tissue in the major omentum.
Brandt CT; Leite CR; Manhaes-de-Castro FM; Macedo EM; Silva RP; Castro CM
Acta Cir Bras; 2006; 21(5):285-90. PubMed ID: 16981030
[TBL] [Abstract][Full Text] [Related]
12. Hepatosplenic schistosomiasis mansoni: an immunologic disease.
Warren KS
Bull N Y Acad Med; 1975 Apr; 51(4):545-50. PubMed ID: 1091317
[No Abstract] [Full Text] [Related]
13. Immunological changes in splenectomized versus non splenectomized schistosomal hepatosplenic cases.
Salem SA; Makled MK; Abel-Wahab MF; Sedky A; Montasser MF; Bishara SA; Ragheb MM; Younis TA
J Egypt Soc Parasitol; 1987 Dec; 17(2):785-96. PubMed ID: 3121771
[No Abstract] [Full Text] [Related]
14. Clinical forms of human Schistosoma mansoni infection are associated with differential activation of T-cell subsets and costimulatory molecules.
Martins-Filho OA; Cunha-Melo JR; Lambertucci JR; Silveira AM; Colley DG; Gazzinelli G; Correa-Oliveira R
Dig Dis Sci; 1999 Mar; 44(3):570-7. PubMed ID: 10080152
[TBL] [Abstract][Full Text] [Related]
15. Immune responses during human schistosomiasis mansoni. XVI. Idiotypic differences in antibody preparations from patients with different clinical forms of infection.
Montesano MA; Lima MS; Correa-Oliveira R; Gazzinelli G; Colley DG
J Immunol; 1989 Apr; 142(7):2501-6. PubMed ID: 2494260
[TBL] [Abstract][Full Text] [Related]
16. Schistosoma mansoni: immunodepression of hepatic schistosome granuloma formation in mice infected by Trypanosoma cruzi.
Genaro O; Brener Z; Coelho PM
Rev Soc Bras Med Trop; 1986; 19(1):35-7. PubMed ID: 3120250
[No Abstract] [Full Text] [Related]
17. [Levels of anti-typhoid agglutinins in patients with hepatosplenic schistosomiasis].
Yasuda MA; Ferri RG; Yasuda PH; Netto CF; da Silva GR; Ferreira JM
Rev Saude Publica; 1982 Apr; 16(2):107-13. PubMed ID: 7146817
[No Abstract] [Full Text] [Related]
18. Tumour necrosis factor in hepatosplenic schistosomiasis.
Zwingenberger K; Irschick E; Vergetti Siqueira JG; Correia Dacal AR; Feldmeier H
Scand J Immunol; 1990 Feb; 31(2):205-11. PubMed ID: 2106723
[TBL] [Abstract][Full Text] [Related]
19. Association of hepatosplenic schistosomiasis with HLA-DQB1*0201.
Secor WE; del Corral H; dos Reis MG; Ramos EA; Zimon AE; Matos EP; Reis EA; do Carmo TM; Hirayama K; David RA; David JR; Harn DA
J Infect Dis; 1996 Nov; 174(5):1131-5. PubMed ID: 8896524
[TBL] [Abstract][Full Text] [Related]
20. T cell phenotype alterations in hepatosplenic schistosomiasis mansoni normalize after chemotherapy.
Zwingenberger K; Harms G; Vergetti de Siqueira JG; Correia Dacal AR; Jansen-Rosseck R; Bienzle U; Feldmeier H
Immunobiology; 1989 Oct; 179(4-5):342-52. PubMed ID: 2515152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
